Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results
November 10, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2022 commercial revenue of $4.7 million Delivered year-over-year recurring revenue growth of 34% Reaffirms full year 2022 commercial revenue guidance of at least $17.0 million ...
Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022
November 02, 2022 08:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System
October 10, 2022 08:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference
October 04, 2022 08:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference
September 12, 2022 09:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value
August 12, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Rejects Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management Adopts Limited Duration Stockholder Rights Plan LOWELL, Mass., Aug. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro...
Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results
August 12, 2022 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports second quarter 2022 commercial revenue of $3.9 million Lowers full year 2022 commercial revenue guidance to at least $17.0 million Implements organizational restructuring plan to right-size...
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022
August 09, 2022 08:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management
June 30, 2022 14:33 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports First Quarter 2022 Financial Results
May 10, 2022 06:00 ET
|
Rapid Micro Biosystems, Inc.
Reports first quarter 2022 commercial revenue of $4.2 million Reaffirms full year 2022 commercial revenue outlook range of $27 million to $32 million, representing growth of approximately 25% to...